Healthcare Pharmaceutical Biotech

Pentixapharm Announces IND Submission to FDA for Phase 3 PANDA Study of First-in-Class CXCR4-Targeted Cardiovascular Diagnostic

May 11, 2026 2:20 AM

Pentixapharm Holding AG (Frankfurt Prime Standard:PTP), a clinical-stage biotech developing novel radiopharmaceuticals today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its lead CXCR4-targeted diagnostic program in treatment resistant hypertension with underlying Primary Aldosteronism. The IND supports the initiation of the Pentixapharm's U.S.-focused Phase 3 PANDA...

Read more

Your Doctor Might Offer You a CBD Gummy Through Medicare. Here's What They Won't Tell You

May 10, 2026 12:40 PM

Imagine your mother is 74 years old. She has cancer. She's on blood thinners, blood pressure medication, and chemotherapy. Her doctor sits down with her and says Medicare will now cover CBD hemp products - up to $500 a year - and suggests she try them for pain and anxiety. She asks: has this been tested? Is it safe for someone on my medications? Did the government check? The answer to all three questions, right now, is no. That is not...

Read more

Memopryl Official Website Examined in 2026: Consumer Verification Guide for Bill Gates Dementia Recipe, Morgan Freeman Honey Trick, Steve Martin Alzheimer's Cure, and Memory Supplement Search Terms

May 9, 2026 7:15 PM

Advertorial Disclosure: This article is a paid advertorial published for informational and consumer-education purposes. It contains affiliate links. If a purchase is made through links in this article, a commission may be earned at no additional cost to the reader. Medical Disclaimer: This article does not provide medical advice. Memopryl is a dietary supplement marketed for cognitive support. It is not intended to diagnose, treat, cure, or...

Read more

WellBridge Surgical Named 2026 Best Places to Work in Indiana

May 9, 2026 8:00 AM

The statewide survey and awards program is designed to evaluate participating organizations and honor those with the highest levels of employee satisfaction and engagement in the workplace. "The Best Places to Work program is a great way for organizations to take the temperature of their culture and how it's resonating with today's workers," says Indiana Chamber President and CEO Vanessa Green Sinders. "We salute each of this year's winners for...

Read more

From Finance to Dentistry: Dr. Charles Howenstine on Bringing Discipline and Early Detection Back to Patient Care

May 9, 2026 7:30 AM

In an era where healthcare often feels reactive rather than proactive, Dr. Charles Howenstine is restoring a model of care rooted in discipline, clarity, and early intervention. Based in Stevensville, Michigan, his approach to dentistry reflects a professional journey that began not in a clinic, but in the structured, analytical world of finance. A Nontraditional Path Built on Discipline and Analysis Originally from Rice Lake, Wisconsin, Dr....

Read more

MemoPryl Reviews & Complaints: Legit Nootropic Supplement or Fake Testimonial Hype?

May 8, 2026 7:20 PM

Disclaimers: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new dietary supplement, especially if you take prescription medications, are pregnant or nursing, or have existing health conditions. This article contains affiliate links. If you click these links and make a purchase, a commission may be earned at no additional cost to you....

Read more

MEDVi QUAD Reviewed: Compounded Prescription Facts, FDA Warning Explained, and What Men Should Verify Before Enrolling

May 8, 2026 7:05 PM

Disclaimers: This article is for informational purposes only and does not constitute medical advice. MEDVi QUAD is a compounded prescription medication requiring evaluation by a licensed clinician. Compounded medications are not FDA-approved as finished drug products. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. Prescription approval is not guaranteed and depends on an...

Read more

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology

May 8, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that Nucro-Technics Inc. ("Nucro-Technics"), a Toronto-based contract research organization collaborating with Onco on preclinical development, has commenced advanced bioanalytical work in support of the Company's ongoing non-GLP1 pharmacokinetic (PK) and biodistribution animal model study involving A83B4C63, the active...

Read more

EU Regulators Say Charlotte's Web Hemp CBD Safety "Cannot Be Established" - So Why Is It Entering Medicare?

May 8, 2026 5:20 PM

A growing conflict between international scientific findings and U.S. healthcare policy is raising urgent questions about whether Medicare beneficiaries are being exposed to cannabinoid products that have not been proven safe. In March 2026, the European Food Safety Authority (EFSA) issued a formal scientific rejection of Charlottes Web hemp product submission concluding that the safety of a carbon dioxide extract derived from Cannabis sativa L....

Read more

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026

May 8, 2026 4:30 PM

Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2026. Revenue for the quarter ended March 31, 2026 was $10.1 million compared to $13.9 million for the quarter ended March 31, 2025, a decrease of $3.8 million or 27.3%. The Company had an operating loss of $1.1 million in the quarter ended March 31, 2026 compared to operating income in the quarter ended March 31,...

Read more

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

May 8, 2026 11:25 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that Zacks Small-Cap Research has published an updated research report raising its 2026 revenue and EPS forecasts, while reaffirming its $4.50 per share valuation. The updated report projects revenue growth from a record $65.3 million in fiscal year 2025 to $103.2 million in 2026 - up from Zacks'...

Read more

Experts Warn GOP: Don't Side With Hospital Lobby Over Trump 340B Reforms

May 8, 2026 10:25 AM

The Hospital Accountability Project convened a roundtable of leading health policy experts this week to examine abuse in the federal 340B Drug Pricing Program and the urgent need for reform. "President Trump is pushing a reform that could prevent billions in waste, fraud, and abuse," said West Cuthbert of American Resolve Action, who moderated the May 5 roundtable discussion. "The administration is trying to bring transparency to a program that...

Read more

TruMerit and Credivera Issue First Verifiable Digital Credentials for Global Healthcare Professionals

May 8, 2026 10:00 AM

TruMerit, a global leader in healthcare workforce development and credential verification, today announced that it has issued its first verifiable digital credentials to healthcare professionals through a new partnership with Credivera, marking a major step forward in secure, portable credential verification for the global healthcare workforce. The first group of digital credentials has been awarded to nurses and other healthcare professionals...

Read more

Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule

May 8, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided an update on the status of the Company's listing on The Nasdaq Stock Market ("Nasdaq"). On May 6, 2026, Jaguar received a decision letter from the Nasdaq Hearings Panel ("Panel") granting the Company's request for an extension to demonstrate compliance with the Nasdaq Listing Rules. As previously disclosed, on May 1, 2026, Jaguar received written notification from the...

Read more

Black Book Nurses Week Survey: Payer Delays Are Reaching the Bedside Before Hospital C-Suite Sees the Damage

May 8, 2026 8:15 AM

Black Book Research today released Payer Friction at the Bedside, the third report in its Nurses Week 2026 registered nurse survey series, warning that hospitals and payers are underestimating how deeply prior authorization, denials, discharge delays, formulary restrictions, and opaque payer decisions are affecting nurses and patients in real time. The new report, based on a survey of 119 hospital-based registered nurses conducted between...

Read more

Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam

May 8, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics engineered to minimize abuse and overdose risk, announced that CEO, Dr. Lynn Kirkpatrick, presented as an invited speaker and was featured on a panel at the first Pain Therapeutics Summit Europe held in Amsterdam May 7-8, 2026. This meeting gathered experts from...

Read more

Monthly Letter April - Increased Activity and Growing Implementations

May 8, 2026 7:45 AM

iZafe Group (STO:IZAFE-B) - April was characterized by a high level of activity across several areas. We continue to see strong interest in Dosell, both in Sweden and internationally, while the focus is increasingly shifting from procurement processes and dialogue to actual implementation and scaling. During the month, we continued to strengthen the organization in order to meet growing demand and manage an increasing number of start-ups,...

Read more

Judge Takes CMS HEMP-MARIJUANA CBD Program Under Advisement - As Evidence Mounts That Medicare May Be Moving Ahead of FDA Science

May 8, 2026 7:15 AM

The future of federal cannabinoid policy now sits with the court after Judge Trevor N. McFadden took under advisement an emergency motion to halt the Centers for Medicare & Medicaid Services' (CMS) cannabinoid access program. The case, Smart Approaches to Marijuana (SAM), et al. v. Robert F. Kennedy Jr., et al. Case No. 1:26-cv-01081 (D.D.C.), challenges whether CMS exceeded its authority by allowing provider mediated furnishing of certain...

Read more

Genflow Biosciences PLC Announces Exercise of Warrants and Issue of Equity

May 8, 2026 5:50 AM

Genflow (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a biotechnology company focused on the development of gene therapies for age-related diseases announces that it has received notices of exercise of warrants for a total of 30,756,577 new ordinary shares in the capital of the Company (the "Warrant Shares") with gross proceeds amounting to £359,374.99. The Warrant Shares comprise: 2,631,578 new ordinary shares being issued pursuant to...

Read more

Dr. Andrea Joy Smith to Present Oral Conscious Sedation Lecture at Sacramento Society of the National Dental Association General Meeting

May 7, 2026 11:05 PM

Dr. Andrea Joy Smith, DDS, will serve as the featured presenter during the Sacramento Society of the National Dental Association's upcoming general meeting on May 28, 2026, where she will provide a lecture focused on oral conscious sedation. The Sacramento Society of the National Dental Association is a chapter of the National Dental Association, which supports dental professionals through education, networking, advocacy, and community...

Read more